Injective (INJ) is currently trading at $2.87, reflecting a minor decline of 1.23% over the past 24 hours. The price has fluctuated between a high of $2.91 and a low of $2.80 within this period, indicating a tight daily range of 0.11%, suggesting limited volatility.

The trading volume stands at approximately 43.14 million, with a volume-to-market cap ratio of 15.05%, indicating healthy trading activity relative to its market capitalization. The hourly moving averages show positive momentum, with the 8 SMA at $2.83 up 1.55% and the 13 SMA at $2.84 up 1.05%, suggesting short-term bullishness.

The Relative Strength Index (RSI) is currently at 55 for the 1-hour period, reflecting a neutral to slightly bullish sentiment. However, the 7-day RSI is at 50, indicating a balanced market with no clear trend, while the 14-day change shows a decline of 5.92%, suggesting potential bearish pressure over a longer timeframe.

In the last 30 days, INJ has experienced a price increase of 1.30%, indicating some recovery potential, yet the longer-term view remains mixed due to the recent downward trends. The all-time high of $52.62 remains significantly above the current price, indicating a substantial gap to fill, which could attract speculative interest if market conditions improve.

Overall, while there are signs of short-term bullishness from moving averages and the RSI, the longer-term indicators present mixed signals. Given the recent volatility, price declines, and overall market conditions, the recommendation is to Hold INJ at this time, as traders should assess further movements before making a decisive entry or exit.